UNIVERSITY OF CALIFORNIA SAN DIEGO

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1960-11-18

Employees: 10K

Market Cap: -

Website: http://www.ucsd.edu

Clinical Trials

Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Phase 2

Completed

Conditions: Hereditary Hemorrhagic Telangiectasia (HHT)

Interventions: Drug: Submucosal Bevacizumab

First Posted Date: 2011-07-26

Last Posted Date: 2019-12-04

Lead Sponsor: University of California, San Diego

Target Recruit Count: 10

Registration Number: NCT01402531

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States

Per-Oral Endoscopic Myotomy

Completed

Conditions: Achalasia

Interventions: Procedure: Per-oral enodscopic myotomy

First Posted Date: 2011-07-26

Last Posted Date: 2020-03-10

Lead Sponsor: University of California, San Diego

Target Recruit Count: 100

Registration Number: NCT01402518

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States

Transvaginal NOTES Sleeve Gastrectomy

Withdrawn

Conditions: Obesity

Interventions: Procedure: Transvaginal NOTES sleeve gastrectomy

First Posted Date: 2011-07-26

Last Posted Date: 2020-03-31

Lead Sponsor: University of California, San Diego

Registration Number: NCT01402505

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States

Natural Orifice Translumenal Endoscopic Surgery (NOTES): Laparoscopic Assisted Transvaginal Ventral Hernia Repair

Conditions: Umbilical Hernia
Ventral Hernia

Interventions: Procedure: transvaginal NOTES ventral hernia repair

First Posted Date: 2011-07-20

Last Posted Date: 2018-05-01

Lead Sponsor: University of California, San Diego

Target Recruit Count: 50

Registration Number: NCT01398215

Locations: 🇺🇸
University of California, San Diego Medical Center, San Diego, California, United States

Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation

Early Phase 1

Completed

Conditions: Rosacea

Interventions: Drug: Vehicle cream
Drug: Topical aminocaproic acid (ACA) mixed with Vanicream

First Posted Date: 2011-07-20

Last Posted Date: 2019-09-13

Lead Sponsor: University of California, San Diego

Target Recruit Count: 15

Registration Number: NCT01398280

Locations: 🇺🇸
University of California, San Diego Perlman Ambulatory Center, La Jolla, California, United States

Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Phase 2

Completed

Conditions: Hereditary Hemorrhagic Telangiectasia (HHT)

Interventions: Drug: Bevacizumab

First Posted Date: 2011-07-19

Last Posted Date: 2019-09-06

Lead Sponsor: University of California, San Diego

Target Recruit Count: 20

Registration Number: NCT01397695

Locations: 🇺🇸
University of California, San Diego Medical Center, San Diego, California, United States

Nitisinone (NTBC) In Different Age Groups Of Patients With Alkaptonuria

Phase 2

Completed

Conditions: Alkaptonuria

Interventions: Drug: Nitisinone

First Posted Date: 2011-07-08

Last Posted Date: 2021-04-22

Lead Sponsor: University of California, San Diego

Target Recruit Count: 8

Registration Number: NCT01390077

Locations: 🇺🇸
University of California San Diego, La Jolla, California, United States

Continuous Infraclavicular Nerve Blocks: Needle Versus Catheter Local Anesthetic Bolus

Phase 4

Withdrawn

Conditions: Nerve Block

Interventions: Procedure: Local Anesthetic given via perineural catheter for infraclavicular nerve block.
Procedure: Local Anesthetic given via needle for infraclavicular nerve block

First Posted Date: 2011-06-21

Last Posted Date: 2013-01-18

Lead Sponsor: University of California, San Diego

Registration Number: NCT01377545

Locations: 🇺🇸
UCSD CTRI, Hillcrest, San Diego, California, United States

Examination of the Anti-inflammatory and Insulin Sensitizing Properties of Doxycycline in Humans

Phase 4

Completed

Conditions: Type 2 Diabetes
Obesity

Interventions: Other: Placebo
Drug: Doxycycline

First Posted Date: 2011-06-17

Last Posted Date: 2020-01-13

Lead Sponsor: University of California, San Diego

Target Recruit Count: 39

Registration Number: NCT01375491

Locations: 🇺🇸
University of California San Diego Clinical trials Research Institute, La Jolla, California, United States

EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: SKY0402

First Posted Date: 2011-05-06

Last Posted Date: 2021-03-25

Lead Sponsor: University of California, San Diego

Target Recruit Count: 14

Registration Number: NCT01349140

Locations: 🇺🇸
UCSD Medical Center Hillcrest, San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy